Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

DynoSense Closes $9.4 Million from China-US Investors for Remote Health Monitoring

publication date: Aug 25, 2015
DynoSense, a San Jose medical device company, closed a $9.4 million Series A funding round from a group of China-US investors that included WI Harper Group; JKOM Cloud Health Technology; Plug and Play Tech Center; Jinmao Capital; and Wilson, Sonsini, Goodrich and Rosati. With the new capital, DynoSense will seek US regulatory approval and commercialization of Dyno, a remote, multi-function device that captures 33 health metrics, uploads the data to the cloud, and then transfers it to medical professionals. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital